Comparison of R-miniCHOP with R-Bendamustine (R-B) in diffuse large B-cell Lymphoma (DLBCL) in elderly and comorbid patients

被引：0
|
作者：
Hammersen, F. J. [1 ]
Ruethrich, M. M. [1 ]
Wedding, U. [2 ]
Sommer, M. [3 ]
Hochhaus, A. [1 ]
La Rosee, P. [4 ]
机构：
[1] Univ Klinikum Jena, Hamatol internist Onkol, Klin Innere Med 2, Jena, Germany
[2] Univ Klinikum Jena, Palliat Med, Klin Innere Med 2, Jena, Germany
[3] Inst Allgemeinmed Jena, Jena, Germany
[4] Schwarzwald Baar Klinikum Villingen Schwenningen, Klin Innere Med Onkol Hamatol Immunol Infektiol &, Villingen Schwenningen, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2018年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P173
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [1] Comparison between R-mini-CHOP and R-Bendamustine in diffuse large B-cell lymphoma (DLBCL) of elderly and comorbid patients
    Hammersen, F. J.
    Ruethrich, M. M.
    Kleber, M.
    Wedding, U.
    Sommer, M.
    Mueller, D.
    Schlattmann, P.
    Hochhaus, A.
    La Rosee, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 143 - 144
  • [2] R-Mini-CHOP Versus R-Bendamustine As Primary Treatment for Diffuse Large B-Cell Lymphoma (DLBCL) in Elderly and Comorbid Patients
    Hammersen, Jakob
    Ruethrich, Maria Madeleine
    Kleber, Martina
    Wedding, Ulrich
    Sommer, Michael
    Mueller, Daniela
    Schlattmann, Peter
    Hochhaus, Andreas
    La Rosee, Paul
    BLOOD, 2014, 124 (21)
  • [3] Bendamustine plus Rituximab versus R-miniCHOP: which is better for unfit patients with diffuse larger B-cell lymphoma?
    Zhang, Dongdong
    Dong, Youhong
    Zhang, Liling
    JOURNAL OF CHEMOTHERAPY, 2024, 36 (04) : 351 - 353
  • [4] R-miniCHOP versus R-CHOP in elderly patients with diffuse large B-cell lymphoma: A propensity matched population-based study
    Al-Sarayfi, D.
    Brink, M.
    Chamuleau, M. E. D.
    Brouwer, R.
    van Rijn, R. S.
    Issa, D.
    Deenik, W.
    Huls, G.
    Mous, R.
    Vermaat, J. S. P.
    Diepstra, A.
    Zijlstra, J. M.
    van Meerten, T.
    Nijland, M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (02) : 216 - 222
  • [5] R-MINICHOP VERSUS R-COMP IN PATIENTS OVER 70 YEARS WITH DIFFUSE LARGE B CELL LYMPHOMA
    Ortiz Carmen, De Ramon
    Monica, Monsalve
    Pilar, Gomez
    Paola, Beneit
    Ana Maria, Martin-Moreno
    Carmen, Martinez-Chamorro
    Miriam, Moreno
    Antonio, Gutierrez
    Rafael, De la Camara
    Morfa Miguel, Diaz
    Payer Angel, Ramirez
    Ana Belen, Santos
    Maria Teresa, Olave
    Sainz Elena, Ruiz
    Rebeca, Iglesias
    Ana, Lafuente
    Suarez Julio, Garcia
    Carlos, Montalban
    Monica, Estevez
    Marco Jose, Garcia
    Raquel, De Ona
    de la Guia Ana, Lopez
    Victor, Jimenez-Yuste
    Miguel, Canales
    Adolfo, De la Fuente
    HAEMATOLOGICA, 2016, 101 : 17 - 18
  • [6] Acalabrutinib monotherapy in patients (pts) with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
    Dyer, Martin J. S.
    De Vos, Sven
    Ruan, Jia
    Flowers, Christopher
    Maddocks, Kami J.
    Rule, Simon
    Hamdy, Ahmed M.
    Izumi, Raquel
    Slatter, J. Greg
    Cheung, Jean
    Frigualt, Melanie M.
    Wei, Helen
    Mourya, Sanchita
    Hunder, Naomi N. H.
    Fowler, Nathan Hale
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Total Cost of Care in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
    Gatwood, Justin
    Masaquel, Anthony
    Ross, Ryan
    Sheinson, Danny
    Hossain, Farah
    Li, Jia
    James, Cameron
    Fox, David
    BLOOD, 2022, 140 : 7906 - 7907
  • [8] A Phase 2b Study of Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
    Kalakonda, Nagesh
    Cavallo, Federica
    Follows, George
    Goy, Andre
    Vermaat, Joost S. P.
    Casasnovas, Olivier
    Lavee, Orly
    Maerevoet, Marie
    Zijlstra, Josee
    Bakhshi, Sameer
    Bouabdallah, Reda
    Choquet, Sylvain
    Gurion, Ronit
    Hill, Brian
    Jaeger, Ulrich
    Sancho, Juan-Manuel
    Schuster, Michael
    Thieblemont, Catherine
    De la Cruz, Fatima
    Egyed, Miklos
    Mishra, Sourav
    Offner, Fritz
    Vassilakopoulos, Theodoros
    Warzocha, Krzysztof
    McCarthy, Daniel
    Ma, Xiwen
    Corona, Kelly
    Saint-Martin, Jean-Richard
    Joshi, Anita
    Shah, Jatin
    Van den Neste, Eric
    Canales, Miguel
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S248 - S249
  • [9] Clinical Pharmacology of CTL019 in Patients with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL)
    Awasthi, Rakesh
    Tam, Constantine S.
    Jaeger, Ulrich
    Jaglowski, Samantha
    Foley, Stephen Ronan
    Van Besien, Koen
    Wagner-Johnston, Nina D.
    Kersten, Marie Jose
    Schuster, Stephen J.
    Salles, Gilles Andre
    Maziarz, Richard Thomas
    Anak, Oezlem
    Pacaud, Lida Bubuteishvili
    Gazi, Lucien
    Waldron, Edward
    Hamilton, Jason
    Pruteanu, Iulian
    Tai, Feng
    Mueller, Karen Thudium
    Waller, Edmund K.
    BLOOD, 2017, 130
  • [10] Magrolimab in Combination with Rituximab plus Chemotherapy in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
    Maakaron, Joseph
    Asch, Adam S.
    Popplewell, Leslie L.
    Collins, Graham P.
    Flinn, Ian W.
    Ghosh, Nilanjan
    Keane, Colin
    Ku, Matthew
    Mehta, Amitkumar
    Roschewski, Mark
    O'Hear, Carol
    Ren, Xuehan
    Villa, Bertha
    Lal, Indu
    Smith, Sonali M.
    Advani, Ranjana H.
    BLOOD, 2022, 140 : 3728 - 3730
12345